Boris Ajdinovic is the Head of Institute for the Nuclear Medicine, Military Medical Academy, Belgrade. He is a Professor and has obtained Doctor of Science degree in Nuclear Medicine. He has graduated from University of Belgrade in 1978 and has obtained Nuclear Medicine specialization. He is an Instructor of Nuclear Medicine for students specializing in internal medicine and surgery from 1985. He has over 250 specialized and scientific published articles and is the recipient of many awards and honors
A graduate of the National Defense Medical Center (NDMC), Kuo-Cheng Lu joined the NDMC faculty in 1985 after having training at Internal Medicine and Clinical Nephrology. He devoted the first two decades of his career to the clinical care of dialysis patients at Tri-Service General Hospital and private Kou-Cheng clinic in Taipei, Taiwan. At the same time, he conducted bone biopsy (Histomorphometric study) research for renal patients, especially on the osteitis fibrosa cystica (SHPT) and calcitriol therapy. After managing of private dialysis clinic for ten years, he moved to the Nephrology division of Cardinal-Tien Hospital, an affiliated teaching hospital of Fu-Jen Catholic University. In 2003, he was elected as the chairman of Department of Medicine, Cardinal-Tien Hospital. Since 2003, Dr. Lu’s research has moved toward translation study in renal dystrophy focusing on SHPT treatment. The most significant contributions involved an ongoing trans-disciplinary study of renal bone diseases with a goal of identifying significant differences in renal bone diseases among the different degree of turnover status. Dr. Lu also teaches at other medical schools such as Taipei Medical University and National Defense Medical Center. Moreover, Dr. Lu supervised many PhD students who study in the field of bone cell regulation in various clinical diseases. In 2015, Dr. Lu was recruited to join Fu-Jen Catholic University as Associate Dean of College of Medicine, Fu-Jen Catholic University. Since then, Dr. Lu became more interested in potential of large observational data, biology, and pathophysiology with available renal bone disorders, both at the bedside and through translation study. In Dec 2016, this effort was rewarded when he was selected as the Present of Taiwan Society of Nephrology, devoted to improve the high quality multidisciplinary care for CKD patients in Taiwan. Currently, Dr. Lu also pays attention to study on the possible AKI in the development of CKD. This work led him to organize the faculties across many medical centers in Taiwan for the study on how AKI induces CKD, which may be used to address health care quality. Over the years, Dr. Lu has had the privilege of advocating CKD healthcare education in Tanzania, China, Japan and doing research with the professionals in these counties. Dr. Lu also published papers in the field of music therapy in dialysis patients. Currently, Dr. Lu spends much time on the strengthening international collaboration among the Taiwan Society of Nephrology (TSN) and Nephrology Society of Japan, Korea, Thailand and Malaysia to enhance the academic communicate, share the clinical experience and promote CKD education programs.
Clinical Medical Education, Renal Osteodystrophy, Secondary Hyperparathyroidism (SHPT) & Vitamin-D, Dialysis